Jennifer L. Carter - Net Worth and Insider Trading

Jennifer L. Carter Net Worth

The estimated net worth of Jennifer L. Carter is at least $3,752 dollars as of 2024-04-26. Jennifer L. Carter is the Director of OncoCyte Corp and owns about 1,525 shares of OncoCyte Corp (OCX) stock worth over $3,752. Details can be seen in Jennifer L. Carter's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jennifer L. Carter has not made any transactions after 2022-08-16 and currently still holds the listed stock(s).

Transaction Summary of Jennifer L. Carter

To

Jennifer L. Carter Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jennifer L. Carter owns 4 companies in total, including OncoCyte Corp (OCX) , DFP Healthcare Acquisitions Corp (DFPHU) , and The Oncology Institute Inc (TOI) among others .

Click here to see the complete history of Jennifer L. Carter’s form 4 insider trades.

Insider Ownership Summary of Jennifer L. Carter

Ticker Comapny Transaction Date Type of Owner
OCX OncoCyte Corp 2022-08-16 director
DFPHU DFP Healthcare Acquisitions Corp 2020-03-10 director
TOI The Oncology Institute Inc 2020-03-10 director
CMAX CareMax Inc 2021-06-08 director

Jennifer L. Carter Latest Holdings Summary

Jennifer L. Carter currently owns a total of 1 stock. Jennifer L. Carter owns 1,525 shares of OncoCyte Corp (OCX) as of August 16, 2022, with a value of $3,752.

Latest Holdings of Jennifer L. Carter

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OCX OncoCyte Corp 2022-08-16 1,525 2.46 3,752

Holding Weightings of Jennifer L. Carter


Jennifer L. Carter Form 4 Trading Tracker

According to the SEC Form 4 filings, Jennifer L. Carter has made a total of 1 transactions in OncoCyte Corp (OCX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in OncoCyte Corp is the acquisition of 525 shares on August 16, 2022, which cost Jennifer L. Carter around $9,975.

Insider Trading History of Jennifer L. Carter

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jennifer L. Carter Trading Performance

GuruFocus tracks the stock performance after each of Jennifer L. Carter's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jennifer L. Carter is -57.74%. GuruFocus also compares Jennifer L. Carter's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jennifer L. Carter within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jennifer L. Carter's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jennifer L. Carter

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.84 -57.74 -55.22 -81.77
Relative Return to S&P 500(%) 7.19 -49.69 -50.23 -84.07

Jennifer L. Carter Ownership Network

Ownership Network List of Jennifer L. Carter

No Data

Ownership Network Relation of Jennifer L. Carter


Jennifer L. Carter Owned Company Details

What does OncoCyte Corp do?

Who are the key executives at OncoCyte Corp?

Jennifer L. Carter is the director of OncoCyte Corp. Other key executives at OncoCyte Corp include 10 percent owner Broadwood Partners Lp , Interim CEO Josh Riggs , and other: Former Director John Peter Gutfreund .

OncoCyte Corp (OCX) Insider Trades Summary

Over the past 18 months, Jennifer L. Carter made no insider transaction in OncoCyte Corp (OCX). Other recent insider transactions involving OncoCyte Corp (OCX) include a net purchase of 29,247,638 shares made by Broadwood Partners Lp , a net purchase of 283,898 shares made by Andrew Arno , and a net purchase of 55,000 shares made by Alfred D Kingsley .

In summary, during the past 3 months, insiders sold 0 shares of OncoCyte Corp (OCX) in total and bought 2,457,288 shares, with a net purchase of 2,457,288 shares. During the past 18 months, 0 shares of OncoCyte Corp (OCX) were sold and 3,850,820 shares were bought by its insiders, resulting in a net purchase of 3,850,820 shares.

OncoCyte Corp (OCX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

OncoCyte Corp Insider Transactions

No Available Data

Jennifer L. Carter Mailing Address

Above is the net worth, insider trading, and ownership report for Jennifer L. Carter. You might contact Jennifer L. Carter via mailing address: C/o Dfp Sponsor Llc, 780 Third Avenue, 37th Floor, New York Ny 10017.

Discussions on Jennifer L. Carter

No discussions yet.